Navigation Links
Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer
Date:10/3/2007

of in vitro cell lines and has shown inhibition of human tumor growth in certain animal xenograft models when tested against standard comparative agents. The in vitro activity was seen across multiple cell lines including cell lines known to be sensitive to taxanes as well as cell lines known to be resistant to taxanes. Taxane sensitive cell lines in which TPI 287 has shown activity include cell lines derived from breast cancer, uterine cancer and non-small cell lung cancer. Taxane resistant cell lines in which TPI 287 has shown activity include cell lines derived from breast cancer, colon cancer and prostate cancer.

About Tapestry Pharmaceuticals, Inc.

Tapestry Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of proprietary therapies for the treatment of cancer.

For more information about Tapestry and its technologies, visit Tapestry's website at http://www.tapestrypharma.com.

Forward-Looking Statements

Statements in this press release that are not historical facts are "forward-looking statements" that involve risks and uncertainties. Forward- looking statements can be identified by the use of words such as "opportunities," "trends," "potential," "estimates," "may," "will," "should," "anticipates," "expects," "hopes," "plans" or comparable terminology or by discussions of strategy. Such forward-looking statements include the statements that the Company will initiate additional Phase 2 trials of TPI 287 and initiate an oral Phase 1b/2 trial. Such statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from the results, performance or achievements expressed or implied by such forward- looking statements. Such risks, uncertainties and other factors include risks that clinical trials for TPI 287 will be delayed due to institutional approvals, p
'/>"/>

SOURCE Tapestry Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Tapestry Pharmaceuticals to Present Data on TPI 287 at the 2007 AACR Annual Meeting
2. Malvern initiates European user group meetings for chemical imaging
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... , May 6, 2015 CVS Health (NYSE: CVS ... Baltimore locations that sustained heavy fire damage during ... in Baltimore over the past week or ... is ahead," said CVS Health President and CEO Larry Merlo ... path to better health. There is no better way that we ...
(Date:5/6/2015)... , May 06, 2015 Research and ... the addition of the "Cannulas Market by ... Injector, Infusion, Venous, Microcannula), Material (Plastic, Metal) & ... Forecast to 2020" report to their offering. ... to grow at a CAGR of 5.6% from ...
(Date:5/6/2015)... , May 6, 2015  Rigrodsky & Long, P.A.: ... Pharmaceuticals, Inc. (NASDAQ GM: AERI )? , Did you ... inclusive? , Did you lose money in your investment in ... rights? Rigrodsky & Long, P.A. , ... , announces that a complaint has been filed in the United ...
Breaking Medicine Technology:CVS Health Announces it Will Rebuild Baltimore CVS/pharmacy Locations 2Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating 2Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating 3SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 2SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 3
... , NORCROSS, Ga., Nov. 23 Immucor, Inc. (Nasdaq: ... to the blood transfusion industry, today announced that access to ... Conference in New York, NY will be available via a ... scheduled for Tuesday, December 1, 2009, at 12:30 p.m. Eastern ...
... RICHMOND, Calif., Nov. 23 Transcept Pharmaceuticals, Inc. (Nasdaq: ... with the U.S. Food and Drug Administration (FDA) on January ... New Drug Application (NDA) for Intermezzo ® ... Letter, received by Transcept on October 28, 2009, indicated that ...
Cached Medicine Technology:Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo(R) Complete Response Letter 2
(Date:5/6/2015)... Chesapeake Regional Medical Center is ... to acquire Intuitive Surgical, Inc.’s latest model of ... includes enhanced surgical technique capabilities, which can be ... wide spectrum of specialties. Its advancements allow patients ... recovery times. , “As the only independent, community-based ...
(Date:5/6/2015)... TMG Health, the leading national provider ... Medicare Part D and Managed Medicaid markets, was one ... category at the BCI North America Awards, a program ... outstanding contribution of business continuity professionals and organizations living ... the USA and Canada. The North America Awards were ...
(Date:5/6/2015)... 06, 2015 Inversion Studios, a ... yoga and Pilates classes, provides personalized individual instruction ... starting with its new Pilates Ring magic circle. ... becoming leaner, stronger, more centered and graceful, Inversion ... fresh venue to healthy fitness through yoga and ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Follow ... sanitizers are increasing, driven by the rising consumer awareness ... spread of contagious diseases. Hand washing is becoming a ... consumer apprehension over contracting infections. Periodic outbreak of Avian ... recent Ebola virus disease (EVD) epidemic in ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Locally owned, Greek ... was recognized this past week as having one the best ... EVOO, imported from the Peloponnese region of Greece and known ... in the category of Medium Olive Oil, which is ... everyday use”. With over 700 producer applicants from 25 ...
Breaking Medicine News(10 mins):Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 3Health News:TMG Health Recognized by the Business Continuity Institute 2Health News:TMG Health Recognized by the Business Continuity Institute 3Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 3Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 3Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 4Health News:Greek Extra Virgin Olive Oil, Laconiko Wins Gold at the NYIOOC and Is Featured in Olive Oil Times as One of Greece's Best EVOO's for 2015 2
... of twins and their mothers to see if there was ... years // of life and children's antisocial behavior by age ... to have increased problems with conduct and more antisocial behavior ... after the twins' birth and the likeliness of antisocial behavior ...
... California School of Dentistry has devised a test to predict ... to measure the relative concentration of various sugar chains called ... as those present in the teeth surface. Some sugar chains ... bacteria to bond with the tooth. Each individual sugar chain ...
... have shown that oral examination may not foretell much ... Earlier patients suffering from obstructive sleep apnea syndrome ... sleep. And so snoring was known as one of ... as the condition of fragmented sleep is associated with ...
... According to latest research rheumatoid arthritis patients have twice ... the heart's ability // to pump blood, compared to ... study showed patients with rheumatoid arthritis are at an ... of arthritis, and this risk continues throughout the course ...
... by Northwestern University about the effects of epidural pain relief ... at the early stages of labor does not increase the ... final term were observed for the study. All were delivering ... were given epidural in the early stages of labor tended ...
... found a herb used in traditional Indian medicine to ... levels // in a manner similar to prescription drugs. ... called salacia oblonga, which is native to regions of ... enzymes that break down carbohydrates in the body. These ...
Cached Medicine News:
Double-ended. Blunt and semi sharp 5 mm tips. Designated most popular model or size....
Double-ended. 6 mm x 9 mm and 6 mm x 11 mm tips....
Designated most popular model or size. 3 mm tip....
Designated most popular model or size. Slightly angled, 2 mm wide....
Medicine Products: